• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测心房颤动患者院内心脏死亡率的机器学习模型。

Machine learning model for predicting in-hospital cardiac mortality among atrial fibrillation patients.

作者信息

Lv Huasheng, Bi Xuehua, Shang Shuai, Wei Meng, Zhou Xianhui, Wang Kai, Tang Baopeng, Lu Yanmei

机构信息

Department of Pacing and Electrophysiology, Department of Cardiac Electrophysiology and Remodeling, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.

Department of Medical Engineering and Technology, Xinjiang Medical University, Urumqi, 830017, China.

出版信息

Sci Rep. 2025 Aug 12;15(1):29554. doi: 10.1038/s41598-025-14579-8.

DOI:10.1038/s41598-025-14579-8
PMID:40797067
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12343966/
Abstract

This study developed and validated a machine learning (ML) model to predict in-hospital cardiac mortality in 18,727 atrial fibrillation (AF) patients using electronic medical record data. Four ML algorithms-random forest, extreme gradient boosting (XGBoost), deep neural network, and logistic regression-were applied to 79 clinical variables, including demographics, vital signs, comorbidities, lifestyle factors, and laboratory parameters. The XGBoost model achieved the best performance, with an area under the curve of 0.964 ± 0.014 in the training set and 0.932 ± 0.057 in the validation set, alongside precision, accuracy, and recall of 0.909 ± 0.021, 0.910 ± 0.021, and 0.897 ± 0.038, respectively. Shapley Additive Explanations identified key predictors such as thyroid function indices (e.g., total triiodothyronine, total thyroxine), procalcitonin, N-terminal pro-brain natriuretic peptide, and international normalized ratio. This interpretable model holds promise for improving early risk stratification and individualized care in AF patients. Prospective, multi-center validation is needed to confirm its generalizability.

摘要

本研究开发并验证了一种机器学习(ML)模型,该模型使用电子病历数据预测18727例心房颤动(AF)患者的院内心脏死亡率。将四种ML算法——随机森林、极端梯度提升(XGBoost)、深度神经网络和逻辑回归——应用于79个临床变量,包括人口统计学、生命体征、合并症、生活方式因素和实验室参数。XGBoost模型表现最佳,训练集曲线下面积为0.964±0.014,验证集曲线下面积为0.932±0.057,精确率、准确率和召回率分别为0.909±0.021、0.910±0.021和0.897±0.038。夏普利值加法解释法确定了关键预测因素,如甲状腺功能指标(如总三碘甲状腺原氨酸、总甲状腺素)、降钙素原、N末端脑钠肽前体和国际标准化比值。这种可解释的模型有望改善AF患者的早期风险分层和个性化护理。需要进行前瞻性、多中心验证以确认其可推广性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff0f/12343966/11150ba74bd4/41598_2025_14579_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff0f/12343966/96d06d916f95/41598_2025_14579_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff0f/12343966/6b09210c21b1/41598_2025_14579_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff0f/12343966/3f5b43f0eb68/41598_2025_14579_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff0f/12343966/11150ba74bd4/41598_2025_14579_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff0f/12343966/96d06d916f95/41598_2025_14579_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff0f/12343966/6b09210c21b1/41598_2025_14579_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff0f/12343966/3f5b43f0eb68/41598_2025_14579_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff0f/12343966/11150ba74bd4/41598_2025_14579_Fig4_HTML.jpg

相似文献

1
Machine learning model for predicting in-hospital cardiac mortality among atrial fibrillation patients.用于预测心房颤动患者院内心脏死亡率的机器学习模型。
Sci Rep. 2025 Aug 12;15(1):29554. doi: 10.1038/s41598-025-14579-8.
2
Supervised Machine Learning Models for Predicting Sepsis-Associated Liver Injury in Patients With Sepsis: Development and Validation Study Based on a Multicenter Cohort Study.用于预测脓毒症患者脓毒症相关肝损伤的监督式机器学习模型:基于多中心队列研究的开发与验证研究
J Med Internet Res. 2025 May 26;27:e66733. doi: 10.2196/66733.
3
Machine Learning Model for Predicting Coronary Heart Disease Risk: Development and Validation Using Insights From a Japanese Population-Based Study.预测冠心病风险的机器学习模型:基于日本人群研究的见解进行开发与验证
JMIR Cardio. 2025 May 12;9:e68066. doi: 10.2196/68066.
4
Prediction of three-year all-cause mortality in patients with heart failure and atrial fibrillation using the CatBoost model.使用CatBoost模型预测心力衰竭合并心房颤动患者的三年全因死亡率。
BMC Cardiovasc Disord. 2025 Jul 4;25(1):466. doi: 10.1186/s12872-025-04928-w.
5
Interpretable prediction of hospital mortality in bleeding critically ill patients based on machine learning and SHAP.基于机器学习和SHAP对出血性危重症患者医院死亡率的可解释预测
BMC Med Inform Decis Mak. 2025 Jul 15;25(1):263. doi: 10.1186/s12911-025-03101-9.
6
Development of an interpretable machine learning model for frailty risk prediction in older adult care institutions: a mixed-methods, cross-sectional study in China.老年护理机构衰弱风险预测的可解释机器学习模型的开发:中国的一项混合方法横断面研究。
BMJ Open. 2025 Jul 5;15(7):e095460. doi: 10.1136/bmjopen-2024-095460.
7
Construction and validation of HBV-ACLF bacterial infection diagnosis model based on machine learning.基于机器学习的HBV-ACLF细菌感染诊断模型的构建与验证
BMC Infect Dis. 2025 Jul 1;25(1):847. doi: 10.1186/s12879-025-11199-5.
8
Utilizing machine learning models for predicting outcomes in acute pancreatitis: development and validation in three retrospective cohorts.利用机器学习模型预测急性胰腺炎的预后:三个回顾性队列中的开发与验证
BMC Med Inform Decis Mak. 2025 Jul 11;25(1):261. doi: 10.1186/s12911-025-03103-7.
9
EVALUATION OF PROGNOSTIC RISK MODELS BASED ON AGE AND COMORBIDITY IN SEPTIC PATIENTS: INSIGHTS FROM MACHINE LEARNING AND TRADITIONAL METHODS IN A LARGE-SCALE, MULTICENTER, RETROSPECTIVE STUDY.基于年龄和合并症的脓毒症患者预后风险模型评估:大规模、多中心、回顾性研究中机器学习与传统方法的见解
Shock. 2025 Jul 1;64(1):56-64. doi: 10.1097/SHK.0000000000002562.
10
Significant adverse prognostic events in patients with urosepsis: a machine learning based model development and validation study.尿脓毒症患者的重大不良预后事件:一项基于机器学习的模型开发与验证研究。
Front Cell Infect Microbiol. 2025 Aug 8;15:1623109. doi: 10.3389/fcimb.2025.1623109. eCollection 2025.

本文引用的文献

1
Transcriptomics, Proteomics and Bioinformatics in Atrial Fibrillation: A Descriptive Review.心房颤动中的转录组学、蛋白质组学和生物信息学:描述性综述
Bioengineering (Basel). 2025 Feb 4;12(2):149. doi: 10.3390/bioengineering12020149.
2
Anillin interacts with RhoA to promote tumor progression in anaplastic thyroid cancer by activating the PI3K/AKT pathway.膜收缩蛋白与RhoA相互作用,通过激活PI3K/AKT信号通路促进间变性甲状腺癌的肿瘤进展。
Endocrine. 2025 Apr;88(1):211-222. doi: 10.1007/s12020-024-04145-z. Epub 2024 Dec 30.
3
The impact of thyroid disorder on cardiovascular disease: Unraveling the connection and implications for patient care.
甲状腺疾病对心血管疾病的影响:揭示两者之间的联系及其对患者护理的意义。
Int J Cardiol Heart Vasc. 2024 Oct 23;55:101536. doi: 10.1016/j.ijcha.2024.101536. eCollection 2024 Dec.
4
Development of a risk score for predicting one-year mortality in patients with atrial fibrillation using XGBoost-assisted feature selection.使用 XGBoost 辅助特征选择开发预测心房颤动患者一年死亡率的风险评分。
Kardiol Pol. 2024;82(10):941-948. doi: 10.33963/v.phj.101842. Epub 2024 Aug 14.
5
Permanent and Persistent Atrial Fibrillations Are Independent Risk Factors of Mortality after Severe COVID-19.永久性和持续性心房颤动是重症 COVID-19 后死亡的独立危险因素。
J Clin Med. 2024 May 26;13(11):3112. doi: 10.3390/jcm13113112.
6
Thyroid dysfunction in nonvalvular atrial fibrillation and clinical outcomes.非瓣膜性心房颤动中的甲状腺功能障碍与临床结局。
Endocrine. 2024 Oct;86(1):239-245. doi: 10.1007/s12020-024-03838-9. Epub 2024 Apr 22.
7
Multi-trait analysis characterizes the genetics of thyroid function and identifies causal associations with clinical implications.多性状分析描绘了甲状腺功能的遗传学特征,并确定了与临床意义相关的因果关联。
Nat Commun. 2024 Jan 30;15(1):888. doi: 10.1038/s41467-024-44701-9.
8
Identification and validation of an explainable prediction model of acute kidney injury with prognostic implications in critically ill children: a prospective multicenter cohort study.识别并验证一种对危重症儿童急性肾损伤具有预后意义的可解释预测模型:一项前瞻性多中心队列研究。
EClinicalMedicine. 2024 Jan 5;68:102409. doi: 10.1016/j.eclinm.2023.102409. eCollection 2024 Feb.
9
Thyroid dysfunction and mortality in cardiovascular hospitalized patients.心血管内科住院患者的甲状腺功能障碍与死亡率
Cardiovasc Endocrinol Metab. 2024 Jan 5;13(1):e0299. doi: 10.1097/XCE.0000000000000299. eCollection 2024 Mar.
10
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2023 ACC/AHA/ACCP/HRS 指南:心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2024 Jan 2;149(1):e1-e156. doi: 10.1161/CIR.0000000000001193. Epub 2023 Nov 30.